{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:02:25Z","timestamp":1761897745957},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"DOI":"10.7759\/cureus.33364","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T20:11:17Z","timestamp":1672863077000},"source":"Crossref","is-referenced-by-count":4,"title":["Case Report and Literature Review of Cardiac Amyloidosis: A Not-So-Rare Cause of Heart Failure"],"prefix":"10.7759","author":[{"given":"Patr\u00edcia","family":"Baptista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Moura de Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Dias-Frias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.07.022","article-title":"Cardiac amyloidosis: an underdiagnosed\/underappreciated disease","volume":"67","author":"Manolis AS","year":"2019","unstructured":"Manolis AS, Manolis AA, Manolis TA, Melita H. Cardiac amyloidosis: an underdiagnosed\/underappreciated disease. Eur J Intern Med. 2019, 67:1-13. 10.1016\/j.ejim.2019.07.022","journal-title":"Eur J Intern Med"},{"key":"ref2","article-title":"Cardiac amyloidosis: epidemiology, clinical manifestations, and diagnosis","author":"Fontana M","year":"2022","unstructured":"Fontana M. Cardiac amyloidosis: epidemiology, clinical manifestations, and diagnosis. Dardas TF (ed): UpToDate, Waltham; 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2022.12.006","article-title":"Clinical profile of patients with cardiac amyloidosis in India","author":"Mohan B","year":"2022","unstructured":"Mohan B, Singh S, Tandon R, et al.. Clinical profile of patients with cardiac amyloidosis in India. Indian Heart J. 2022, 10.1016\/j.ihj.2022.12.006","journal-title":"Indian Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi OK","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018, 28:10-21. 10.1016\/j.tcm.2017.07.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-021-00626-4","article-title":"Amyloidosis with cardiac involvement: identification, characterization, and management","volume":"16","author":"Jamal F","year":"2021","unstructured":"Jamal F, Rosenzweig M. Amyloidosis with cardiac involvement: identification, characterization, and management. Curr Hematol Malig Rep. 2021, 16:357-66. 10.1007\/s11899-021-00626-4","journal-title":"Curr Hematol Malig Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2019.1662723","article-title":"Amyloid transthyretin cardiac amyloidosis: diagnosis and management","volume":"17","author":"Di Giovanni B","year":"2019","unstructured":"Di Giovanni B, Gustafson D, Delgado DH. Amyloid transthyretin cardiac amyloidosis: diagnosis and management. Expert Rev Cardiovasc Ther. 2019, 17:673-81. 10.1080\/14779072.2019.1662723","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg FL","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:2872-91. 10.1016\/j.jacc.2019.04.003","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23572","article-title":"Cardiac amyloidosis- a review of current literature for the practicing physician","volume":"44","author":"Ash S","year":"2021","unstructured":"Ash S, Shorer E, Ramgobin D, et al.. Cardiac amyloidosis- a review of current literature for the practicing physician. Clin Cardiol. 2021, 44:322-31. 10.1002\/clc.23572","journal-title":"Clin Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.37616\/2212-5043.1016","article-title":"Cardiac amyloidosis-an underdiagnosed cause of heart failure in the elderly","volume":"32","author":"Nazir T","year":"2020","unstructured":"Nazir T, Nuffati M. Cardiac amyloidosis-an underdiagnosed cause of heart failure in the elderly. J Saudi Heart Assoc. 2020, 32:98-102. 10.37616\/2212-5043.1016","journal-title":"J Saudi Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, et al.. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021, 42:1554-68. 10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/wjnm.WJNM_9_19","article-title":"Bone scintigraphy imaging of cardiac amyloidosis","volume":"18","author":"Kuria IM","year":"2019","unstructured":"Kuria IM, Gitau SN, Makhdomi KB. Bone scintigraphy imaging of cardiac amyloidosis. World J Nucl Med. 2019, 18:314-6. 10.4103\/wjnm.WJNM_9_19","journal-title":"World J Nucl Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","author":"Quarta CC","year":"2017","unstructured":"Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al.. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur Heart J. 2017, 38:1905-8. 10.1093\/eurheartj\/ehx047","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1751057","article-title":"Multimodality imaging in the diagnosis and assessment of cardiac amyloidosis","volume":"21","author":"Velaga J","year":"2022","unstructured":"Velaga J, Liew C, Choo Poh AC, Lee PT, Lath N, Low SC, Bharadwaj P. Multimodality imaging in the diagnosis and assessment of cardiac amyloidosis. World J Nucl Med. 2022, 21:173-83. 10.1055\/s-0042-1751057","journal-title":"World J Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.121.009025","article-title":"Cardiac amyloidosis: multimodality imaging of disease activity and response to treatment","volume":"14","author":"Patel RK","year":"2021","unstructured":"Patel RK, Fontana M, Ruberg FL. Cardiac amyloidosis: multimodality imaging of disease activity and response to treatment. Circ Cardiovasc Imaging. 2021, 14:e009025. 10.1161\/CIRCIMAGING.121.009025","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.787618","article-title":"Multimodality imaging in the evaluation and prognostication of cardiac amyloidosis","volume":"9","author":"Scheel PJ 3rd","year":"2022","unstructured":"Scheel PJ 3rd, Mukherjee M, Hays AG, Vaishnav J. Multimodality imaging in the evaluation and prognostication of cardiac amyloidosis. Front Cardiovasc Med. 2022, 9:787618. 10.3389\/fcvm.2022.787618","journal-title":"Front Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2113","article-title":"Use of biomarkers to diagnose and manage cardiac amyloidosis","volume":"23","author":"Castiglione V","year":"2021","unstructured":"Castiglione V, Franzini M, Aimo A, et al.. Use of biomarkers to diagnose and manage cardiac amyloidosis. Eur J Heart Fail. 2021, 23:217-30. 10.1002\/ejhf.2113","journal-title":"Eur J Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131636-case-report-and-literature-review-of-cardiac-amyloidosis-a-not-so-rare-cause-of-heart-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:13Z","timestamp":1707508393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131636-case-report-and-literature-review-of-cardiac-amyloidosis-a-not-so-rare-cause-of-heart-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.33364","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}